Literature DB >> 21213953

Tumour suppressors: Selective justice.

Nicola McCarthy.   

Abstract

Year:  2011        PMID： 21213953     DOI： 10.1038/nrc2987

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

2.  Selective activation of p53-mediated tumour suppression in high-grade tumours.

Authors:  Melissa R Junttila; Anthony N Karnezis; Daniel Garcia; Francesc Madriles; Roderik M Kortlever; Fanya Rostker; Lamorna Brown Swigart; David M Pham; Youngho Seo; Gerard I Evan; Carla P Martins
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962
  2 in total
  1 in total

1.  Anti-cancer activity of a novel small molecule compound that simultaneously activates p53 and inhibits NF-κB signaling.

Authors:  Sun Gwan Hwang; Jinah Park; Joo Young Park; Cheol Hyoung Park; Ki-Ho Lee; Jeong Woo Cho; Jong-Ik Hwang; Jae Young Seong
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.